TGFB1 and neoplasm: In breast cancer cells, TGF-β treatment strongly promoted tumor organoids and tumor spheres formation; and these effects were inhibited by TβRI kinase inhibitor SB431542 (Supplementary Fig. 3a, b), demonstrating that TGF-β signaling indeed play a positive role in supporting stem-cell-like properties.